Clinical Benefits of Switching Type 2 Diabetes Patients From Human Insulins to Insulin Analogs

Problemy Endokrinologii - Russian Federation
doi 10.14341/probl201359677-79
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Endocrinology Research Centre

Related search

Clinical Study of Treatment Switching From Premixed Insulin to Basal Insulin Combined With Oral Hypoglycemic Drugs in Patients With Type 2 Diabetes

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

Much Ado About Nothing? A Real-World Study of Patients With Type 2 Diabetes Switching Basal Insulin Analogs

Advances in Therapy
MedicinePharmacology
2014English

Achieve Control: A Pragmatic Clinical Trial of Insulin Glargine 300 U/mL Versus Other Basal Insulins in Insulin-Naïve Patients With Type 2 Diabetes

Postgraduate Medicine
Medicine
2016English

Pdb64 - Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Effectiveness of Insulin Analogs Compared With Human Insulins in Pregnant Women With Diabetes Mellitus: Systematic Review and Meta-Analysis

Revista Brasileira de Ginecologia e Obstetricia
GynecologyObstetrics
2019English

Clinical Outcomes After Switching From Premixed Insulin to Basal Insulin in Patients With Type 2 Diabetes Mellitus in Everyday Care in the Gulf Region: The I-Talent Study.

International Journal of Advanced Research
2018English

Teaching Patients With Type 2 Diabetes to Self-Administer Insulin

Australian journal of general practice
Medicine
2019English

Real World Outcomes of Adding Rapid-Acting Insulin Versus Switching to Analog Premix Insulin Among US Patients With Type 2 Diabetes Treated With Insulin Glargine

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2013English

Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes Receiving Basal–Bolus Therapy

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy